Angela C. Hirbe, MD, PhD, Associate Professor of Medicine and Pediatrics, Director, Adult Neurofibromatosis Clinical Program, WashU Medicine Division of Oncology, along with Stephen T. Oh, MD, PhD, Associate Professor of Medicine, Co-Chief, WashU Medicine Division of Hematology recently were selected for The American Society for Clinical Investigation (ASCI) 2025 Members.
The ASCI is a nonprofit medical honor society composed of more than 3,000 physician-scientists representing all medical specialties. The Society is dedicated to the advancement of research that extends understanding of diseases and improves treatment, and members are committed to mentoring future generations of physician-scientists.
Founded in 1908, the ASCI is one of the nation’s oldest medical honor societies and is among the few organizations focused on the special role of physician-scientists in research, clinical care, and medical education, as well as leadership positions in academic medicine and the life sciences industry.
“I am thrilled to be elected to ASCI. It is truly an honor to join so many esteemed physician-scientist colleagues who have inspired me to pursue my passion of advancing biomedical research for the betterment of human health. I am incredibly grateful to my mentors and trainees who made this possible.”
Each year, the ASCI Council considers membership nominations of several hundred physician-scientists — aged 50 years or younger — and recommends up to 100 candidates for election based on outstanding scholarly achievement. Election is a milestone in the physician-scientist career path, and the ASCI holds its members to the highest standards of integrity, professionalism, mutual respect, and collegiality. Along with the Association of American Physicians and American Physician Scientists Association, the ASCI convenes an annual scientific meeting in Chicago. With the guidance of the Diversity, Equity, and Inclusion Committee, the Society has established programs and processes to achieve equity and meaningful inclusion for people of all identities, with a focus on physician-scientists who are underrepresented in medicine and science (UiMS).
Being elected to ASCI is a great honor. The society represents the core of my professional life—science, medicine, and education. I am so grateful for the guidance provided by my mentors over the years and the amazingly supportive environment at Washington University that has allowed my research and clinical practice to flourish. I look forward to continuing my mission to improve the lives of patients with cancer predisposition syndromes through early cancer detection and development of novel therapeutic strategies and am thrilled to now be a part of the American Society of Clinical Investigation.
The 99 new members elected for 2025 come from 46 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 25, 2025, as part of the AAP/ASCI/APSA Joint Meeting, April 25–27, at the Swissotel Chicago.